THE INNOVATIVE SOLUTION FOR DIABETES
We offer an exceptional solution
- A potential first in class drug with a unique mechanism for the oral treatment of T2D
- A drug that:
- shows powerful effect on glucose homeostasis in animal models
- shows several added advantageous effects
- is covered by strong IP
- shows powerful effect on glucose homeostasis in animal models
- Ongoing pre-clinical studies in preparation for First in Human studies (2021)
- Large interest from big pharma
”Curiosity is what drives me. I’ve dedicated most of my career to identifying a new treatment for type 2 diabetes, and we’ve come a long way. As we’re heading towards launching the first clinical trials, we’ve never been closer to a solution that could revolutionize the treatment of type 2 diabetes.”
Research collaborations and funding
The Team
The development of the new compound is run by a Swedish research company and entails a completely new solution to the global challenge with type 2 diabetes. We are a dedicated team with more than 20 years of experience in this field of research.